157 related articles for article (PubMed ID: 38722955)
1. Mutation of SIVA, a candidate metastasis gene identified from clonally related bilateral breast cancers, promotes breast cancer cell spread in vitro and in vivo.
Vermehren-Schmaedick A; Peto M; Wagoner W; Chiotti KE; Ramsey E; Wang X; Rakshe S; Minnier J; Sears R; Spellman P; Luoh SW
PLoS One; 2024; 19(5):e0302856. PubMed ID: 38722955
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities.
Tan M; Yao J; Yu D
Cancer Res; 1997 Mar; 57(6):1199-205. PubMed ID: 9067293
[TBL] [Abstract][Full Text] [Related]
3. Hypochlorite-induced oxidative stress elevates the capability of HDL in promoting breast cancer metastasis.
Pan B; Ren H; Lv X; Zhao Y; Yu B; He Y; Ma Y; Niu C; Kong J; Yu F; Sun WB; Zhang Y; Willard B; Zheng L
J Transl Med; 2012 Mar; 10():65. PubMed ID: 22462581
[TBL] [Abstract][Full Text] [Related]
4. Integrin α3β1 can function to promote spontaneous metastasis and lung colonization of invasive breast carcinoma.
Zhou B; Gibson-Corley KN; Herndon ME; Sun Y; Gustafson-Wagner E; Teoh-Fitzgerald M; Domann FE; Henry MD; Stipp CS
Mol Cancer Res; 2014 Jan; 12(1):143-154. PubMed ID: 24002891
[TBL] [Abstract][Full Text] [Related]
5. Apoptosis inhibitor ARC promotes breast tumorigenesis, metastasis, and chemoresistance.
Medina-Ramirez CM; Goswami S; Smirnova T; Bamira D; Benson B; Ferrick N; Segall J; Pollard JW; Kitsis RN
Cancer Res; 2011 Dec; 71(24):7705-15. PubMed ID: 22037876
[TBL] [Abstract][Full Text] [Related]
6. Plumbagin inhibits proliferation and induces apoptosis of hepatocellular carcinoma by downregulating the expression of SIVA.
Li T; Lv M; Chen X; Yu Y; Zang G; Tang Z
Drug Des Devel Ther; 2019; 13():1289-1300. PubMed ID: 31118568
[No Abstract] [Full Text] [Related]
7. Integrin-dependent response to laminin-511 regulates breast tumor cell invasion and metastasis.
Kusuma N; Denoyer D; Eble JA; Redvers RP; Parker BS; Pelzer R; Anderson RL; Pouliot N
Int J Cancer; 2012 Feb; 130(3):555-66. PubMed ID: 21387294
[TBL] [Abstract][Full Text] [Related]
8. Recombinant PAPP-A resistant insulin-like growth factor binding protein 4 (dBP4) inhibits angiogenesis and metastasis in a murine model of breast cancer.
Smith YE; Toomey S; Napoletano S; Kirwan G; Schadow C; Chubb AJ; Mikkelsen JH; Oxvig C; Harmey JH
BMC Cancer; 2018 Oct; 18(1):1016. PubMed ID: 30348128
[TBL] [Abstract][Full Text] [Related]
9. [Establishment of a bioluminescent MDA-MB-231 cell line for in vivo imaging of human triple-negative breast cancer xenograft].
Wang K; Xie SM; He JJ; Ren Y; Xia HB; Zhang XW
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Nov; 31(11):1812-8. PubMed ID: 22126756
[TBL] [Abstract][Full Text] [Related]
10. Using an in-vivo syngeneic spontaneous metastasis model identifies ID2 as a promoter of breast cancer colonisation in the brain.
Kijewska M; Viski C; Turrell F; Fitzpatrick A; van Weverwijk A; Gao Q; Iravani M; Isacke CM
Breast Cancer Res; 2019 Jan; 21(1):4. PubMed ID: 30642388
[TBL] [Abstract][Full Text] [Related]
11. Zoledronic acid inhibits visceral metastases in the 4T1/luc mouse breast cancer model.
Hiraga T; Williams PJ; Ueda A; Tamura D; Yoneda T
Clin Cancer Res; 2004 Jul; 10(13):4559-67. PubMed ID: 15240548
[TBL] [Abstract][Full Text] [Related]
12. BRD7 suppresses invasion and metastasis in breast cancer by negatively regulating YB1-induced epithelial-mesenchymal transition.
Niu W; Luo Y; Zhou Y; Li M; Wu C; Duan Y; Wang H; Fan S; Li Z; Xiong W; Li X; Li G; Ren C; Li H; Zhou M
J Exp Clin Cancer Res; 2020 Feb; 39(1):30. PubMed ID: 32028981
[TBL] [Abstract][Full Text] [Related]
13. FGF13 promotes metastasis of triple-negative breast cancer.
Johnstone CN; Pattison AD; Harrison PF; Powell DR; Lock P; Ernst M; Anderson RL; Beilharz TH
Int J Cancer; 2020 Jul; 147(1):230-243. PubMed ID: 31957002
[TBL] [Abstract][Full Text] [Related]
14. Exome sequencing of primary breast cancers with paired metastatic lesions reveals metastasis-enriched mutations in the A-kinase anchoring protein family (AKAPs).
Kjällquist U; Erlandsson R; Tobin NP; Alkodsi A; Ullah I; Stålhammar G; Karlsson E; Hatschek T; Hartman J; Linnarsson S; Bergh J
BMC Cancer; 2018 Feb; 18(1):174. PubMed ID: 29433456
[TBL] [Abstract][Full Text] [Related]
15. Autocrine/Paracrine Human Growth Hormone-stimulated MicroRNA 96-182-183 Cluster Promotes Epithelial-Mesenchymal Transition and Invasion in Breast Cancer.
Zhang W; Qian P; Zhang X; Zhang M; Wang H; Wu M; Kong X; Tan S; Ding K; Perry JK; Wu Z; Cao Y; Lobie PE; Zhu T
J Biol Chem; 2015 May; 290(22):13812-29. PubMed ID: 25873390
[TBL] [Abstract][Full Text] [Related]
16. Expression of Siva-1 protein or its putative amphipathic helical region enhances cisplatin-induced apoptosis in breast cancer cells: effect of elevated levels of BCL-2.
Chu F; Barkinge J; Hawkins S; Gudi R; Salgia R; Kanteti PV
Cancer Res; 2005 Jun; 65(12):5301-9. PubMed ID: 15958577
[TBL] [Abstract][Full Text] [Related]
17. Long Non-Coding RNA (LncRNA) HOXA11-AS Promotes Breast Cancer Invasion and Metastasis by Regulating Epithelial-Mesenchymal Transition.
Li W; Jia G; Qu Y; Du Q; Liu B; Liu B
Med Sci Monit; 2017 Jul; 23():3393-3403. PubMed ID: 28701685
[TBL] [Abstract][Full Text] [Related]
18. MCL-1 inhibition provides a new way to suppress breast cancer metastasis and increase sensitivity to dasatinib.
Young AI; Law AM; Castillo L; Chong S; Cullen HD; Koehler M; Herzog S; Brummer T; Lee EF; Fairlie WD; Lucas MC; Herrmann D; Allam A; Timpson P; Watkins DN; Millar EK; O'Toole SA; Gallego-Ortega D; Ormandy CJ; Oakes SR
Breast Cancer Res; 2016 Dec; 18(1):125. PubMed ID: 27931239
[TBL] [Abstract][Full Text] [Related]
19. Suppression of growth, migration and invasion of highly-metastatic human breast cancer cells by berbamine and its molecular mechanisms of action.
Wang S; Liu Q; Zhang Y; Liu K; Yu P; Liu K; Luan J; Duan H; Lu Z; Wang F; Wu E; Yagasaki K; Zhang G
Mol Cancer; 2009 Oct; 8():81. PubMed ID: 19796390
[TBL] [Abstract][Full Text] [Related]
20. The Wnt-5a-derived hexapeptide Foxy-5 inhibits breast cancer metastasis in vivo by targeting cell motility.
Säfholm A; Tuomela J; Rosenkvist J; Dejmek J; Härkönen P; Andersson T
Clin Cancer Res; 2008 Oct; 14(20):6556-63. PubMed ID: 18927296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
